scientists will also be focusing on extremely-prolonged-performing GLP-1 analogs which will demand dosing just once per month or maybe much less often. These prolonged-launch versions could help it become even much easier to keep on with having GLP-1s.  Semaglutide imitates the actions of GLP 1 by stimulating insulin creation in the pancreatic be